Cite
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.
MLA
Wood, Brent L., et al. “Prognostic Significance of ETP Phenotype and Minimal Residual Disease in T-ALL: A Children’s Oncology Group Study.” Blood, vol. 142, no. 24, Dec. 2023, pp. 2069–78. EBSCOhost, https://doi.org/10.1182/blood.2023020678.
APA
Wood, B. L., Devidas, M., Summers, R. J., Chen, Z., Asselin, B., Rabin, K. R., Zweidler-McKay, P. A., Winick, N. J., Borowitz, M. J., Carroll, W. L., Raetz, E. A., Loh, M. L., Hunger, S. P., Dunsmore, K. P., Teachey, D. T., & Winter, S. S. (2023). Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children’s Oncology Group study. Blood, 142(24), 2069–2078. https://doi.org/10.1182/blood.2023020678
Chicago
Wood, Brent L, Meenakshi Devidas, Ryan J Summers, Zhiguo Chen, Barbara Asselin, Karen R Rabin, Patrick A Zweidler-McKay, et al. 2023. “Prognostic Significance of ETP Phenotype and Minimal Residual Disease in T-ALL: A Children’s Oncology Group Study.” Blood 142 (24): 2069–78. doi:10.1182/blood.2023020678.